HMGB1 and neoplasm: Tumor patients showing Cyto-HMGB1 translocation and PD-1+tumor-infiltrating lymphocytes (TILs) pre-treatment exhibit better clinical outcomes, possibly due to HMGB1 release inducing DC maturation via TLR4 activation.